Diabetics who wear insulin pumps appear more likely to experience problems from improper use than a device defect, members of a U.S. government advisory panel said on Friday.
The Food and Drug Administration said problems with insulin pumps have occurred across the industry and asked the panel of outside experts for ways to minimize risks from malfunctions. Makers of the pumps include Medtronic, Roche, and Johnson & Johnson.
About 375,000 adults with type 1 diabetes used the pumps in 2007, up from 130,000 in 2002, the FDA said.
Source.
